BOCA RATON, Fla., June 22, 2020 (Newswire.com) - CūtisCare establishes the CūtisCare Research Fund and will provide multi-year support to the school’s wound care research initiatives. This gift is to be used to support wound care and hyperbaric medicine research and education in the Indiana Center for Regenerative Medicine and Engineering at the Indiana University School of Medicine. Expenditures shall be used for laboratory research and related activities and operations.
CūtisCare Board Chairman and CEO Jim Patrick said, “Research in Regenerative Medicine will pave the way for significant advancements in the field of wound care, and CūtisCare wants to be a part of it.
"Chandan Sen, Ph.D., and his research team at Indiana University have created one of only six clinical research sites in the country participating in a Diabetic Foot Consortium sponsored by the National Institutes of Health. With this donation, we are supporting this team's efforts to bring forward scientific advancements to improve healing outcomes of patients suffering from debilitating, non-healing wounds, and related complications.”
Chandan Sen, Ph.D., commented, “Impacting health care through innovative science requires effective partnership between stakeholders, among whom health care managers play a key role. I thank Mr. Patrick for his continued support of our research program for well over a decade. I welcome CūtisCare’s philanthropic support to improve wound care by enabling cutting-edge scientific innovations.”
Headquartered in Boca Raton, Florida, CūtisCare works with hospitals, academic medical centers, and hospital systems to design customized outpatient wound care and hyperbaric oxygen (HBOT) solutions. With more than 60 years of combined management experience, a commitment to research, and driven by ethics and a culture of compliance, CūtisCare collaborates with its partners to reach and heal people with chronic wounds. To learn more about CūtisCare, visit www.cutiscareusa.com.